Rhythm Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of RYTM for the last quarter is 29.08 M USD, and it's 11.98% higher compared to the previous quarter. The net income of Q2 24 is -32.26 M USD.